Research & Innovation 2021

Dr Ultan McDermott

Dr Ultan McDermott
Dr Ultan McDermott

Presentations at Research & Innovation 2021

Wed24  Feb03:10pm(30 mins)

Session: Seeking novel drug targets for the Discovery pipeline
Room: Conference Hall

Profile of Dr Ultan McDermott

Ultan McDermott is a clinician scientist and has a lifelong interest in understanding how cancer genomes affect response in the clinic to therapy, and more recently the use of genetic screens to identify mechanisms of drug resistance in cancer.
He joined the Wellcome Sanger Institute in 2009 as a Group Leader and member of faculty. Previously he worked as a postdoctoral fellow with Jeff Settleman at Massachusetts General Hospital Cancer Center on high-throughput cancer cell line drug screens and resistance mechanisms. In 2018 he joined AstraZeneca as Chief Scientist in Oncology.
He is a Fellow of the Royal College of Physicians and continues to practice as an oncologist at Addenbrooke’s Hospital in Cambridge.


Dr Argyrides Argyrou
Associate Principal Scientist
Dr Chiara Ceci
Science Communication Manager
Please login to send a Private Message

Hosted By
The European Laboratory Research & Innovation Group Our Vision : To provide outstanding, leading edge knowledge to the life sciences community on an open access basis
Web Site Find us on Facebook Follow us on Twitter

Get the App
Get this event information on your mobile by
going to the appstore or google play and search for 'elrig'
Eventflo Home
copyright ELRIG, eventflo, Labhoo Ltd 2003-2020